dict.md logo
Results for O in English, page 49
oncofetal antigen I
oncofetal antigen M2A
Oncofetal Antigen-immature Laminin Receptor Protein-loaded Autologous Dendritic Cell Vaccine
oncofetal antigens
oncofetal fibronectin
oncofetal glial antigen
oncofetal mRNA-transport protein p65, rat
oncofetal proteins
Oncofetal Tumor Markers
oncofoetal antigen I
OncoGel
Oncogene
oncogene 24p3
oncogene 24p3 protein, human
Oncogene ABL1
ONCOGENE ABL2
ONCOGENE ABLL
Oncogene Activation
ONCOGENE AKT1
ONCOGENE AKT2
ONCOGENE AMV
Oncogene AP2
ONCOGENE ARAF1
ONCOGENE ARG
ONCOGENE AXL
ONCOGENE B-CELL LEUKEMIA 2
ONCOGENE BMYC
ONCOGENE BRAF
ONCOGENE CBL
ONCOGENE CBL2
Oncogene Chimeric Proteins
ONCOGENE COT
ONCOGENE CRK
ONCOGENE CRKL
Oncogene CSF1R
ONCOGENE DBL
Oncogene Deregulation
ONCOGENE DJ1
Oncogene E1A
Oncogene E1B
ONCOGENE ECT2
Oncogene EGF
ONCOGENE ELK1
ONCOGENE EMS1
ONCOGENE EPH
Oncogene ERB A
Oncogene ERB B
ONCOGENE ERBA
ONCOGENE ERBA2
ONCOGENE ERBB
ONCOGENE ERBB2
ONCOGENE ERBB3
ONCOGENE ERBB4
ONCOGENE ERG
Oncogene ETS
ONCOGENE ETS1
ONCOGENE ETS2
ONCOGENE EVI1
Oncogene FES
Oncogene FES, feline sarcoma virus
Oncogene FGR
ONCOGENE FLT
ONCOGENE FMS
ONCOGENE FOS
oncogene FOS-B
ONCOGENE FOSB
Oncogene FPS-FES
Oncogene Fusion
Oncogene Fusion Proteins
Oncogene Fusions
ONCOGENE GLI
ONCOGENE GLI2
ONCOGENE GLI3
ONCOGENE GLI4
Oncogene H-Ras
Oncogene HGFR
ONCOGENE HIS1
ONCOGENE HIS2
ONCOGENE HKR1
ONCOGENE HKR2
ONCOGENE HKR3
ONCOGENE HKR4
ONCOGENE HLM2
ONCOGENE HST
ONCOGENE INT1
ONCOGENE INT1-LIKE 1
ONCOGENE INT2
ONCOGENE INT3
ONCOGENE INT4
ONCOGENE INT6
Oncogene JUN
ONCOGENE JUN-B
ONCOGENE JUN-D
Oncogene K-Ras
Oncogene KIT
ONCOGENE KRAS1
ONCOGENE KRAS2
ONCOGENE LCA
ONCOGENE LCK
ONCOGENE LIPOSARCOMA
ONCOGENE LMYC
ONCOGENE LYN
ONCOGENE LYT 10
Oncogene MAX
ONCOGENE MCF2
Oncogene MCF2 (oncogene DBL)
ONCOGENE MEL
ONCOGENE MET
ONCOGENE MIL
ONCOGENE MOS
Oncogene MYB
Oncogene MYC
ONCOGENE MYC-LIKE-1
Oncogene MYCN
Oncogene N-RAS
ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED
Oncogene NMYC
ONCOGENE NOV
ONCOGENE NRAS
oncogene p47(gag-crk) protein, Avian sarcoma virus
ONCOGENE PE1
ONCOGENE PIM 1
ONCOGENE PIM2
ONCOGENE PIM3
ONCOGENE PKS2
Oncogene Product
Oncogene Product p55(v-myc)
Oncogene Product v jun
Oncogene Product v-jun
Oncogene Products
Oncogene Products v abl
Oncogene Products v erbA
Oncogene Products v erbB
Oncogene Products v fos
Oncogene Products v mos
Oncogene Products v myb
Oncogene Products v rel
Oncogene Products v sis
Oncogene Products v-abl
Oncogene Products v-erbA
Oncogene Products v-erbB
Oncogene Products v-fos
Oncogene Products v-mos
Oncogene Products v-myb
Oncogene Products v-rel
Oncogene Products v-sis
Oncogene Protein
Oncogene Protein 70Z Cbl
Oncogene Protein 70Z-Cbl
Oncogene Protein akt
oncogene protein BNLF-1, Human herpesvirus 4
Oncogene Protein cbl
Oncogene Protein crk
oncogene protein E1--E4, Human papillomavirus type 16
oncogene protein E1, Human papillomavirus type 18
oncogene protein E2, human papilloma virus type 16
oncogene protein E2, Human papillomavirus type 1
oncogene protein E2, Human papillomavirus type 18
oncogene protein E2, Human papillomavirus type 8
oncogene protein E4, human papilloma virus type 1
oncogene protein E4, Human papillomavirus type 16
oncogene protein E4, Human papillomavirus type 18
Oncogene Protein E4, Papillomavirus Type 11
oncogene protein E4, papillomavirus type 6
oncogene protein E4, type 11, Human papillomavirus
oncogene protein E5-E8, bovine papillomavirus type 4
oncogene protein E5, Bovine papillomavirus type 1
oncogene protein E5, Human papillomavirus type 16
oncogene protein E5, Human papillomavirus type 6
oncogene protein E6, Bovine papillomavirus type 1
oncogene protein E6, human papilloma virus type 18
oncogene protein E6, Human papillomavirus type 16
Oncogene Protein E7 Human Papillomavirus Type 8
oncogene protein E7, Bovine papillomavirus type 1
oncogene protein E7, human papilloma virus type 45
oncogene protein E7, Human papillomavirus type 16
oncogene protein E7, Human papillomavirus type 18
oncogene protein E7, Human papillomavirus type 6
oncogene protein E7, Human papillomavirus type 8
Oncogene Protein E7, Papillomavirus
oncogene protein ets
ONCOGENE PROTEIN GP 140 V FMS
Oncogene Protein gp140(v-fms)
Oncogene Protein gp140(v-fms) [Chemical/Ingredient]
Oncogene Protein HER 2
Oncogene Protein HER-2
Oncogene Protein jun
Oncogene Protein mil
Oncogene Protein myb
ONCOGENE PROTEIN P 021 RAS
ONCOGENE PROTEIN P 028 SIS
ONCOGENE PROTEIN P 037 V MOS
ONCOGENE PROTEIN P 055 V FOS
ONCOGENE PROTEIN P 055 V MYC
ONCOGENE PROTEIN P 065 GAG JUN
ONCOGENE PROTEIN P 075 GAG FOS FOX
ONCOGENE PROTEIN P 085 GAG MOS
ONCOGENE PROTEIN P 190 BCR ABL
ONCOGENE PROTEIN P 210 BCR ABL
Oncogene Protein p190(bcr-abl)
Oncogene Protein p21(ras)
Oncogene Protein p21(ras) [Chemical/Ingredient]
Oncogene Protein p210(bcr-abl)
Oncogene Protein p28(v-sis)
Oncogene Protein p37(v-mos)
ONCOGENE PROTEIN P37V MOS
oncogene protein p47 gag-crk, Avian sarcoma virus
Oncogene Protein p55(v-fos)
Oncogene Protein p55(v-myc)
Oncogene Protein p55(v-myc) [Chemical/Ingredient]
ONCOGENE PROTEIN P55V FOS
Oncogene Protein p65(gag-jun)
Oncogene Protein p65(gag-jun) [Chemical/Ingredient]
ONCOGENE PROTEIN P65GAG JUN
Oncogene Protein p75(gag-fos-fox)
ONCOGENE PROTEIN P75GAG FOS FOX
Oncogene Protein p85(gag-mos)
ONCOGENE PROTEIN P85GAG MOS
ONCOGENE PROTEIN PP 059 REL
ONCOGENE PROTEIN PP 060 SRC
ONCOGENE PROTEIN PP 060 V SRC
Oncogene Protein pp59(v-rel)
Oncogene Protein pp60(src)
Oncogene Protein pp60(v-src)
oncogene protein pp60(v-src) (137-157)
Oncogene Protein pp60(v-src) [Chemical/Ingredient]
oncogene protein pp70(fgr), Feline sarcoma virus
oncogene protein pp90 (yes), human
oncogene protein PTI-1, human
oncogene protein Qin, Avian retrovirus
Oncogene Protein rel
oncogene protein ret-II, human
oncogene protein ros, Avian sarcoma virus UR2
oncogene protein ryk
oncogene protein Spi-1
oncogene protein Spi-1, Friend spleen focus-forming virus
Oncogene Protein src
Oncogene protein TCRA
Oncogene Protein tpr met
Oncogene Protein tpr-met
Oncogene Protein tpr-met [Chemical/Ingredient]
oncogene protein trk
oncogene protein UFO
Oncogene Protein v akt
Oncogene Protein v cbl
Oncogene Protein v crk
Oncogene Protein v fes
Oncogene Protein v jun
Oncogene Protein v maf
Oncogene Protein v-akt
Oncogene Protein v-akt [Chemical/Ingredient]
Oncogene Protein v-cbl
Oncogene Protein v-cbl [Chemical/Ingredient]
Oncogene Protein v-crk
Oncogene Protein v-crk [Chemical/Ingredient]
oncogene protein v-ets
Oncogene Protein v-fes
oncogene protein v-fps, Fujinami sarcoma virus
Oncogene Protein v-jun
Oncogene Protein v-maf
Oncogene Protein v-maf [Chemical/Ingredient]
oncogene protein v-sea
Oncogene Protein, cbl
Oncogene Protein, crk
Oncogene Protein, E2 Human Papillomavirus Type 18
Oncogene Protein, E7 Human Papillomavirus Type 6
Oncogene Protein, jun
Oncogene Protein, maf
Oncogene Protein, v-cbl
Oncogene Protein, v-crk
Oncogene Protein, v-maf
Oncogene Proteins
Oncogene Proteins [Chemical/Ingredient]
Oncogene Proteins erbB
Oncogene Proteins fos
Oncogene Proteins mos
Oncogene Proteins myb
Oncogene Proteins rel
Oncogene Proteins sis
Oncogene Proteins v abl
Oncogene Proteins v erbA
Oncogene Proteins v erbB
Oncogene Proteins v fos
Oncogene Proteins v mil
Oncogene Proteins v mos
Oncogene Proteins v myb
Oncogene Proteins v raf
Oncogene Proteins v rel
Oncogene Proteins v sis
Oncogene Proteins v-abl
Oncogene Proteins v-abl [Chemical/Ingredient]
Oncogene Proteins v-erbA
Oncogene Proteins v-erbA [Chemical/Ingredient]
Oncogene Proteins v-erbB
Oncogene Proteins v-erbB [Chemical/Ingredient]
oncogene proteins v-ets
Oncogene Proteins v-fos
Oncogene Proteins v-fos [Chemical/Ingredient]
Oncogene Proteins v-mil
Oncogene Proteins v-mos
Oncogene Proteins v-mos [Chemical/Ingredient]
Oncogene Proteins v-myb
Oncogene Proteins v-myb [Chemical/Ingredient]
Oncogene Proteins v-raf
Oncogene Proteins v-raf [Chemical/Ingredient]
Oncogene Proteins v-rel
Oncogene Proteins v-rel [Chemical/Ingredient]
Oncogene Proteins v-sis
Oncogene Proteins v-sis [Chemical/Ingredient]
Oncogene Proteins, abl
Oncogene Proteins, Chimeric
Oncogene Proteins, E7
Oncogene Proteins, Fusion
Oncogene Proteins, Fusion [Chemical/Ingredient]
Oncogene Proteins, mos
Oncogene Proteins, myb
Oncogene Proteins, rel
Oncogene Proteins, sis
Oncogene Proteins, Viral
Oncogene Proteins, Viral [Chemical/Ingredient]
ONCOGENE PVT-1
ONCOGENE QIN
ONCOGENE RAF1
Oncogene RAS
ONCOGENE RCK
ONCOGENE REL
Oncogene RET
ONCOGENE RHO H12
ONCOGENE RHO H6
ONCOGENE RHO H9
ONCOGENE RMYC
ONCOGENE ROS
ONCOGENE RRAS
ONCOGENE RRAS2
ONCOGENE SEA
Oncogene SIS
ONCOGENE SK, CHICKEN VIRAL
Oncogene SKI
Oncogene SKI wt Allele
ONCOGENE SNO
ONCOGENE SPI1
Oncogene SRC
ONCOGENE TIM
Oncogene TRK
Oncogene V-SIS
ONCOGENE VAV
ONCOGENE VAV1
ONCOGENE VAV2
ONCOGENE VAV3
oncogene viral capsid protein L2, human papillomavirus type 33
oncogene viral capsid protein, L1 human papillomavirus type 16
oncogene viral capsid protein, L2 human papillomavirus type 16
ONCOGENE WNT5A
Oncogene YES-1
ONCOGENE YES1
ONCOGENE YUASA
Oncogene, ABL
Oncogene, ABL1
Oncogene, bcr-v-abl
Oncogene, C-Erb -2
Oncogene, C-ErbB-2
Oncogene, DBL
Oncogene, EGFR
Oncogene, ERBB2
Oncogene, FPS-FES
Oncogene, jun
Oncogene, K-Ras
Oncogene, K-Ras-2
Oncogene, MCF-2
Oncogene, mos
Oncogene, myb
Oncogene, myc
Oncogene, NEU
Oncogene, Neurotrophic Tyrosine Kinase, Receptor, Type 1 Gene
Oncogene, NTRK1
Oncogene, Recessive
Oncogene, rel
Oncogene, RET
Oncogene, sis
Oncogene, src
Oncogene, Transcription Factor
Oncogene, TRKA
Oncogene, v-abl
Oncogene, v-fms
Oncogene, v-mos
Oncogene, v-myb
Oncogene, v-myc
Oncogene, v-rel
Oncogene, v-sis
Oncogene, v-src
Oncogenes
Oncogenes, abl
Oncogenes, bcr-v-abl
Oncogenes, G-Proteins
Oncogenes, Growth Factor
Oncogenes, jun
Oncogenes, mos
Oncogenes, myb
Oncogenes, myc
Oncogenes, Nuclear Protein
Oncogenes, Protein-Kinase
Oncogenes, Recessive
Oncogenes, rel
Oncogenes, sis
Oncogenes, src
Oncogenes, Transcription Factors
Oncogenes, Tyrosine-Kinase
Oncogenes, v-abl
Oncogenes, v-fms
Oncogenes, v-mos
Oncogenes, v-myb
Oncogenes, v-myc
Oncogenes, v-rel
Oncogenes, v-sis
Oncogenes, v-src
Oncogenesis
ONCOGENIC LIPOCALIN 24P3
Oncogenic Osteomalacia
Oncogenic Protein-Associated Protein E6-AP
Oncogenic Retroviridae Proteins
oncogenic suppression activity protein, Shigella flexneri
Oncogenic Virus
Oncogenic Viruses
oncogenic viruslike particle
Oncogens
oncoimmunin-M
ONCOL MED
ONCOL NURS
ONCOL RAD
ONCOL SERV HOSP
OncoLar
oncolipids
oncolipin
Oncologic
Oncologic Complications
Oncologic Nursing
Oncologic Nursings
Oncologic Surgeon
oncologic surgery
oncological
Oncological Nursing
Oncological Nursings
Oncologist
oncologist, medical
Oncologist, Surgical
oncologist/hematologist, pediatric
Oncologist/Neurologist, Pediatric
Oncologists
Oncology
oncology (field)
Oncology Certified Nurse
Oncology Consult note
Oncology Data Management Systems
Oncology drugs
Oncology E/M note
Oncology Evaluation and management note
oncology field
Oncology Group
Oncology Information Systems
Oncology Nurse
Oncology Nurse Specialist
Oncology Nursing
Oncology problem
Oncology Programs
Oncology Radiotherapy Information Management Systems
Oncology Referral note
Oncology Service, Hospital
Oncology Services, Hospital
Oncology tx decision-mgmt
Oncology work-up evaluation
Oncology, Clinical
oncology, dermatologic
Oncology, Experimental
oncology, gynecologic
Oncology, Medical
oncology, neurologic
Oncology, Other
Oncology, Pediatric
Oncology, Pediatrics
Oncology, Pediatrics - Clinical Nurse Specialist - NUCCProviderCodes
oncology, radiation
oncology, surgical
ONCOLOGY; DISEASE STATUS; CHRONIC MYELOGENOUS LEUKEMIA, LIMITED TO PHILADELPHIA CHROMOSOME POSITIVE AND/OR BCR-ABL POSITIVE; ACCELERATED PHASE NOT IN HEMATOLOGIC CYTOGENETIC, OR MOLECULAR REMISSION (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)
ONCOLOGY; DISEASE STATUS; CHRONIC MYELOGENOUS LEUKEMIA, LIMITED TO PHILADELPHIA CHROMOSOME POSITIVE AND/OR BCR-ABL POSITIVE; BLAST PHASE NOT IN HEMATOLOGIC, CYTOGENETIC, OR MOLECULAR REMISSION (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)
ONCOLOGY; DISEASE STATUS; CHRONIC MYELOGENOUS LEUKEMIA, LIMITED TO PHILADELPHIA CHROMOSOME POSITIVE AND/OR BCR-ABL POSITIVE; CHRONIC PHASE NOT IN HEMATOLOGIC, CYTOGENETIC, OR MOLECULAR REMISSION (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)
ONCOLOGY; DISEASE STATUS; CHRONIC MYELOGENOUS LEUKEMIA, LIMITED TO PHILADELPHIA CHROMOSOME POSITIVE AND/OR BCR-ABL POSITIVE; EXTENT OF DISEASE UNKNOWN, STAGING IN PROGRESS, NOT LISTED (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)
ONCOLOGY; DISEASE STATUS; CHRONIC MYELOGENOUS LEUKEMIA, LIMITED TO PHILADELPHIA CHROMOSOME POSITIVE AND/OR BCR-ABL POSITIVE; EXTENT OF DISEASE UNKNOWN, UNDER EVALUATION, NOT LISTED (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)
ONCOLOGY; DISEASE STATUS; CHRONIC MYELOGENOUS LEUKEMIA, LIMITED TO PHILADELPHIA CHROMOSOME POSITIVE AND/OR BCR-ABL POSITIVE; IN HEMATOLOGIC, CYTOGENETIC, OR MOLECULAR REMISSION (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)
ONCOLOGY; DISEASE STATUS; COLON CANCER, LIMITED TO INVASIVE CANCER, ADENOCARCINOMA AS PREDOMINANT CELL TYPE; EXTENT OF DISEASE INITIALLY ESTABLISHED AS T1-3, N0, M0 WITH NO EVIDENCE OF DISEASE PROGRESSION, RECURRENCE, OR METASTASES (FOR USE IN A MEDICARE-
ONCOLOGY; DISEASE STATUS; COLON CANCER, LIMITED TO INVASIVE CANCER, ADENOCARCINOMA AS PREDOMINANT CELL TYPE; EXTENT OF DISEASE INITIALLY ESTABLISHED AS T1-4, N1-2, M0 WITH NO EVIDENCE OF DISEASE PROGRESSION, RECURRENCE, OR METASTASES (FOR USE IN A MEDICAR
ONCOLOGY; DISEASE STATUS; COLON CANCER, LIMITED TO INVASIVE CANCER, ADENOCARCINOMA AS PREDOMINANT CELL TYPE; EXTENT OF DISEASE INITIALLY ESTABLISHED AS T4, N0, M0 WITH NO EVIDENCE OF DISEASE PROGRESSION, RECURRENCE, OR METASTASES (FOR USE IN A MEDICARE-AP
ONCOLOGY; DISEASE STATUS; COLON CANCER, LIMITED TO INVASIVE CANCER, ADENOCARCINOMA AS PREDOMINANT CELL TYPE; EXTENT OF DISEASE UNKNOWN, STAGING IN PROGRESS, OR NOT LISTED (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)
ONCOLOGY; DISEASE STATUS; COLON CANCER, LIMITED TO INVASIVE CANCER, ADENOCARCINOMA AS PREDOMINANT CELL TYPE; M1 AT DIAGNOSIS, METASTATIC, LOCALLY RECURRENT, OR PROGRESSIVE WITH CURRENT CLINICAL, RADIOLOGIC, OR BIOCHEMICAL EVIDENCE OF DISEASE (FOR USE IN A
ONCOLOGY; DISEASE STATUS; COLON CANCER, LIMITED TO INVASIVE CANCER, ADENOCARCINOMA AS PREDOMINANT CELL TYPE; M1 AT DIAGNOSIS, METASTATIC, LOCALLY RECURRENT, OR PROGRESSIVE WITHOUT CURRENT CLINICAL, RADIOLOGIC, OR BIOCHEMICAL EVIDENCE OF DISEASE (FOR USE I
ONCOLOGY; DISEASE STATUS; ESOPHAGEAL CANCER, LIMITED TO ADENOCARCINOMA OR SQUAMOUS CELL CARCINOMA AS PREDOMINANT CELL TYPE; EXTENT OF DISEASE INITIALLY ESTABLISHED AS T1-T3, N0-N1 OR NX (PRIOR TO NEO-ADJUVANT THERAPY, IF ANY) WITH NO EVIDENCE OF DISEASE P
ONCOLOGY; DISEASE STATUS; ESOPHAGEAL CANCER, LIMITED TO ADENOCARCINOMA OR SQUAMOUS CELL CARCINOMA AS PREDOMINANT CELL TYPE; EXTENT OF DISEASE INITIALLY ESTABLISHED AS T4, ANY N, M0 (PRIOR TO NEO-ADJUVANT THERAPY, IF ANY) WITH NO EVIDENCE OF DISEASE PROGRE
ONCOLOGY; DISEASE STATUS; ESOPHAGEAL CANCER, LIMITED TO ADENOCARCINOMA OR SQUAMOUS CELL CARCINOMA AS PREDOMINANT CELL TYPE; EXTENT OF DISEASE UNKNOWN, STAGING IN PROGRESS, OR NOT LISTED (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)
ONCOLOGY; DISEASE STATUS; ESOPHAGEAL CANCER, LIMITED TO ADENOCARCINOMA OR SQUAMOUS CELL CARCINOMA AS PREDOMINANT CELL TYPE; M1 AT DIAGNOSIS, METASTATIC, LOCALLY RECURRENT, OR PROGRESSIVE (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)
ONCOLOGY; DISEASE STATUS; GASTRIC CANCER, LIMITED TO ADENOCARCINOMA AS PREDOMINANT CELL TYPE; CLINICAL OR PATHOLOGIC M0, UNRESECTABLE WITH NO EVIDENCE OF DISEASE PROGRESSION, OR METASTASES (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)
ONCOLOGY; DISEASE STATUS; GASTRIC CANCER, LIMITED TO ADENOCARCINOMA AS PREDOMINANT CELL TYPE; CLINICAL OR PATHOLOGIC M1 AT DIAGNOSIS, METASTATIC, LOCALLY RECURRENT, OR PROGRESSIVE (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)
47 48 49 50 51